# ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

> **NCT00493506** · NA · COMPLETED · sponsor: **Health Enhancement Products, Inc.** · enrollment: 59 (actual)

## Conditions studied

- HIV Infections
- Hepatitis B
- Dyslipidemia

## Interventions

- **DRUG:** ProAlgaZyme

## Key facts

- **NCT ID:** NCT00493506
- **Lead sponsor:** Health Enhancement Products, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2007-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493506, "ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00493506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*